News & Events

April 25, 2022

Increased Cancer Risk Before Age 30 Identified in Some Individuals with Autism

Risk Linked to Those Who Have Co-Occurring Intellectual Disability and/or Birth Defects  A study out of Sweden has discovered that individuals with autism spectrum disorder (ASD) who have comorbid intellectual disability (ID) and/or birth defects were at a higher risk of developing cancer in early life (before age 30) compared to those without ASD. This […]

April 18, 2022

Drug Receives FDA Approval for Treating Schizophrenia and Bipolar Disorder

Medication Zeroes in on Managing Agitation Caused by Both Disorders BioXcel Therapeutics, a Connecticut-based biotech company, has just announced FDA approval of its lead program dexmedetomidine, a sublingual film that is taken orally. The drug, which will be known as Igalmi, was developed to treat agitation that is associated with schizophrenia and bipolar I or […]

April 18, 2022

Altered Gut Microbiota in Children with Autism

New Study Provides Further Evidence that Gut Microbial Dysbiosis is Linked to ASD  New research from China demonstrates that children with autism carry altered gut bacteria compared to children without the disorder. The authors of this new study started their research by recognizing many previous works have already tied altered gut microbiota to autism spectrum […]

April 18, 2022

U.S. Senators Call for a Social Security Beneficiary Advocate

Legislators Suggest Modeling Proposed Role After Existing Taxpayer Advocate Position   Senators Sherrod Brown, D-Ohio, Ron Wyden, D-Ore, and Bob Casey, D-Pa recently sent a letter to President Joe Biden requesting a beneficiary advocate to champion the needs for Social Security participants, including those with disabilities. The senators propose that the advocacy role be modeled on […]

April 11, 2022

Prenatal External Environmental Exposure Linked to Increased Risk of ASD in Offspring

Study Finds That Valproic Acid Exposed Children Had a Higher Risk of Disorder than Non-Exposed Children  Valproic acid (VPA) is a clinical drug used to treat epilepsy and mood disorders. Pregnancy exposure to the medication has been previously associated with a significant increase of autism risk in offspring. This previous research also showed that children […]

April 11, 2022

MIND Institute Reports ASD Characteristics Can Change Significantly Between Ages 3 to 11

About 50% of Children with Autism Had a Notable Change in the Severity of Their Symptoms  The Autism Phenome Project (APP) was started in 2006 at UC Davis’s MIND Institute by Research Director David Amaral. The project includes a collaboration of numerous MIND Institute faculty and staff. It is intended to gather biological and behavioral […]

Show Buttons
Hide Buttons